Form 4: MindMed CEO Robert Barrow Increases Stake in Company
SEC Form 4 Filing
MindMed's CEO, Robert Barrow, has recently increased his holdings in the company through open market purchases.
Summary
- On August 19, 2024, Robert Barrow, the CEO of Mind Medicine (MindMed) Inc., purchased 500 common shares at a weighted average price of $6.31.
- The prices for these shares ranged from $6.29 to $6.33.
- Following this transaction, Mr. Barrow directly owns 565,043 common shares.
- On August 20, 2024, Robert Barrow purchased 500 common shares at a price of $6.12.
- Following this transaction, Mr. Barrow directly owns 565,543 common shares.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the CEO's increased investment in the company, suggesting confidence in its future.
Positives
- The CEO's purchase of additional shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 08/19/2024 | Robert Barrow purchased 500 common shares at a weighted average price of $6.31. |
| 08/20/2024 | Robert Barrow purchased 500 common shares at a price of $6.12. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.